🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
21.73
-0.98 (-4.32%)
At close: Nov 20, 2026, 4:00 PM EST
22.00
+0.27 (1.24%)
After-hours: Nov 20, 2026, 7:41 PM EST

Tango Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
86.84112.2869.5366.3959.97142.75
Short-Term Investments
890.67230.86188.39270.5306.17342.51
Cash & Short-Term Investments
977.5343.14257.92336.89366.13485.26
Cash Growth
539.68%33.04%-23.44%-7.99%-24.55%154.97%
Receivables
----22
Prepaid Expenses
15.1610.198.438.86.574.52
Restricted Cash
-0.43-0.860.570.57
Total Current Assets
992.67353.76266.34346.54375.27492.34
Property, Plant & Equipment
38.4142.4947.5853.4257.776.09
Long-Term Investments
-0.5----
Other Long-Term Assets
2.391.942.572.613.431.73
Total Assets
1,033398.69316.49402.57436.47500.16

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.651.181.62.794.453.23
Accrued Expenses
18.216.4714.7614.1116.239.22
Current Portion of Leases
3.062.742.452.081.771.5
Current Income Taxes Payable
----0.040.05
Current Unearned Revenue
--17.6225.6731.7926.02
Other Current Liabilities
2.261.291.741.291.270.67
Total Current Liabilities
25.1621.6838.1745.9455.5540.69
Long-Term Leases
28.1230.8334.0436.8439.36-
Long-Term Unearned Revenue
--44.7766.6892.09114.72
Total Liabilities
53.2952.51116.98149.46186.99155.41

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.170.140.110.10.090.09
Additional Paid-In Capital
1,757948.97700.63624.08522.61506.76
Retained Earnings
-772.4-603.15-501.56-371.26-269.51-161.34
Comprehensive Income & Other
-4.510.220.340.19-3.71-0.77
Total Common Equity
980.17346.18199.52253.11249.48344.75
Shareholders' Equity
980.17346.18199.52253.11249.48344.75
Total Liabilities & Equity
1,033398.69316.49402.57436.47500.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
31.1833.5736.4938.9241.131.5
Net Cash (Debt)
946.32309.57221.42297.97325483.75
Net Cash Growth
701.64%39.81%-25.69%-8.32%-32.82%165.16%
Net Cash Per Share
6.272.662.033.153.707.79
Filing Date Shares Outstanding
169.46142.69108.11106.7288.287.71
Total Common Shares Outstanding
169.21135.94107.73102.288.1887.6
Working Capital
967.5332.08228.17300.6319.73451.65
Book Value Per Share
5.792.551.852.482.833.94
Tangible Book Value
980.17346.18199.52253.11249.48344.75
Tangible Book Value Per Share
5.792.551.852.482.833.94
Machinery
13.4113.5613.3212.8811.656.25
Construction In Progress
0.17-0.150.040.010.74
Leasehold Improvements
3.723.722.872.862.780.25
SEC Filings: 10-K · 10-Q